SMD Rise Public Company (SMD100) Fair Value & Analysis
Healthcare · TH · Market cap 245M THB
Fair value as of: Jun 24, 2026
Analysis
SMD Rise Public Company (SMD100) currently trades at 1.09 THB, while our model-based Fair Value estimate is 1.41 THB — implying the stock looks roughly 29.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
SMD Rise Public Company Limited engages in the import and distribution of medical devices, equipment, and supplies in Thailand. The company is involved in providing sleep testing services; and rental, hire purchase, and leasing of the medical equipment, as well as offers wellness equipment services. It also imports and distributes products related to radiology and other similar medical products. In addition, the company designs and develops software and information technology systems. Further, it imports and distributes automated medication dispensing machines, pharmaceutical products, medical robots, vascular technologies and equipment, and other related devices. The company was formerly known as SaintMed Public Company Limited and changed its name to SMD Rise Public Company Limited in January 2025. The company was founded in 1998 and is based in Nonthaburi, Thailand.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is SMD Rise Public Company (SMD100) undervalued?
What is the fair value of SMD100?
What is the quality score of SMD100?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.